We have previously written about our successful experience with different data migration scenarios in MainEDC.
We venture to address a rather painful topic – replacing the CRO in an ongoing study by the decision of the sponsor. Yes, sometimes in the business of clinical trials a surgical approach is taken and a professional operation is required.
Let’s not look at the reasons, there may be many, let’s focus on the solution.
Technically, the migration is done in the same way as we detailed in case study 2.
But in this case there is also an ethical dimension. For an organ transplant (and the clinical data of an eCRF is a very sensitive organ) the consent of both the donor and the acceptor is required. Informed consent, of course.
If the sponsor manages to link the first CRO (data donor), the second CRO (data acceptor) and the system provider into one process in a harmonious way, then everything will go according to plan.
The data owner, of course, is the research sponsor, not the CRO. We have chosen a vivid but not quite accurate metaphor, we hope the reader understands and forgives us =)
And the operation plan might look like this:
We are grateful to our clients that the successful cases have been carefully co-designed, no problems occurred during the operations and the results allow us (while maintaining confidentiality) to write such articles and propose solutions to companies who might never have risked such a maneuver had they not known that what is described here is really feasible.
Read more: Data migration in clinical trials and A little more about successful CT data migration
Data Management 365 Presents MainEDC™ AI Coder: A Revolutionary AI-Based Tool for Clinical Research